{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:23:34Z","timestamp":1792545814088,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.brainres.2019.146549","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T11:15:15Z","timestamp":1573470915000},"page":"146549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Anti-N-methyl-D-aspartate receptor encephalitis: A review of pathogenic mechanisms, treatment, prognosis"],"prefix":"10.1016","volume":"1727","author":[{"given":"Qianyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-4456","authenticated-orcid":false,"given":"Xiangqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.146549_b0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13023-014-0157-x","article-title":"Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases","volume":"9","author":"Acien","year":"2014","journal-title":"Orphanet J. Rare Diseases"},{"key":"10.1016\/j.brainres.2019.146549_b0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fneur.2019.00178","article-title":"An assay to determine mechanisms of rapid autoantibody-induced neurotransmitter receptor endocytosis and vesicular trafficking in autoimmune encephalitis","volume":"10","author":"Amedonu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0015","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.brainres.2019.146549_b0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00415-017-8407-1","article-title":"Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey","volume":"264","author":"Bartolini","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1750-3639.2012.00580.x","article-title":"Epileptic encephalitis: the role of the innate and adaptive immune system","volume":"22","author":"Bauer","year":"2012","journal-title":"Brain Pathology (Zurich, Switzerland)."},{"issue":"4","key":"10.1016\/j.brainres.2019.146549_b0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1089\/cap.2015.29000.bjc","article-title":"Neuroleptic malignant syndrome in a boy with NMDA receptor encephalitis","volume":"25","author":"Berg","year":"2015","journal-title":"J. Child Adolesc Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.146549_b0035","article-title":"Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis","volume":"3","author":"Brandt","year":"2016","journal-title":". Neurology(R) Neuroimmunology Neuroinflammation"},{"key":"10.1016\/j.brainres.2019.146549_b0040","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1177\/0883073816643406","article-title":"Approach to the management of pediatric-onset anti-N-methyl-d-aspartate (Anti-NMDA) receptor encephalitis: a case series","volume":"31","author":"Brenton","year":"2016","journal-title":"J. Child Neurol."},{"issue":"8","key":"10.1016\/j.brainres.2019.146549_b0045","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/dmcn.12411","article-title":"Does early treatment improve outcomes in N-methyl-D-aspartate receptor encephalitis?","volume":"56","author":"Byrne","year":"2014","journal-title":"Dev Med Child Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.autneu.2015.08.002","article-title":"Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis","volume":"193","author":"Byun","year":"2015","journal-title":"Auton Neurosci."},{"key":"10.1016\/j.brainres.2019.146549_b0055","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"issue":"1411","key":"10.1016\/j.brainres.2019.146549_b0060","first-page":"89","article-title":"A rare case of anti-N-methyl-D-aspartate receptor encephalitis during pregnancy","volume":"128","author":"Chan","year":"2015","journal-title":"N Z Med J."},{"key":"10.1016\/j.brainres.2019.146549_b0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3389\/fneur.2018.00727","article-title":"Elevation of YKL-40 in the CSF of Anti-NMDAR encephalitis patients is associated with poor prognosis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ane.12723","article-title":"Risk factors for mortality in patients with anti-NMDA receptor encephalitis","volume":"136","author":"Chi","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.brainres.2019.146549_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pediatrneurol.2017.11.010","article-title":"An infant born to a mother with anti-N-methyl-d-aspartate receptor encephalitis","volume":"79","author":"Chourasia","year":"2018","journal-title":"Pediatr Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146549_b0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated withovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0090","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0100","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1212\/WNL.0000000000003414","article-title":"NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: the 2016 Cotzias Lecture","volume":"87","author":"Dalmau","year":"2016","journal-title":"Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0105","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"New England J. Med."},{"key":"10.1016\/j.brainres.2019.146549_b0110","doi-asserted-by":"crossref","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABRencephalitis","volume":"92","author":"de Bruijn","year":"2019","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.brainres.2019.146549_b0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.pediatrneurol.2014.04.030","article-title":"Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis","volume":"51","author":"DeSena","year":"2014","journal-title":"Pediatr Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jca.21363","article-title":"Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: a retrospective review","volume":"30","author":"DeSena","year":"2015","journal-title":"J. Clin. Apheresis"},{"key":"10.1016\/j.brainres.2019.146549_b0125","article-title":"CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis","volume":"2","author":"Desestret","year":"2015","journal-title":"Neurology(R) Neuroimmunology & Neuroinflammation."},{"key":"10.1016\/j.brainres.2019.146549_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acps.12038","article-title":"Rediscovering catatonia: the biography of a treatable syndrome","volume":"441","author":"Fink","year":"2013","journal-title":"Acta Psychiatr Scand Suppl."},{"key":"10.1016\/j.brainres.2019.146549_b0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","article-title":"Cognitive deficits following anti-NMDA receptor encephalitis","volume":"83","author":"Finke","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2019.146549_b0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MOP.0b013e3283402d2f","article-title":"Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents","volume":"22","author":"Florance-Ryan","year":"2010","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.brainres.2019.146549_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1550059416642660","article-title":"EEG Findings May Serve as a Potential Biomarker for Anti-NMDA Receptor Encephalitis","volume":"48","author":"Foff","year":"2017","journal-title":"Clinical EEG Neurosci."},{"key":"10.1016\/j.brainres.2019.146549_b0155","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","article-title":"Analysis of relapses in anti-NMDAR encephalitis","volume":"77","author":"Gabilondo","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.brainres.2019.146549_b0160","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1016\/j.brainres.2019.146549_b0165","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/INF.0000000000001165","article-title":"Pneumocystis Jirovecii Pneumonia in a patient with anti-N-methyl-D-aspartate receptor postherpetic encephalitis","volume":"35","author":"Garcia-Moreno","year":"2016","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.brainres.2019.146549_b0170","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.146549_b0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146549_b0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2018.10.008","article-title":"Confusional state in a pregnant woman: A case of NMDA receptor encephalitis during pregnancy","volume":"325","author":"Grewal","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"Pt 7","key":"10.1016\/j.brainres.2019.146549_b0190","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findingsand tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.146549_b0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","article-title":"Rationale for and use of NMDA receptor antagonists in Parkinson's disease","volume":"102","author":"Hallett","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2019.146549_b0200","article-title":"Transient anti-NMDAR encephalitis in a newborn infant due to transplacental transmission","volume":"2","author":"Hilderink","year":"2015","journal-title":"Neurology(R) Neuroimmunology & Neuroinflammation."},{"issue":"1","key":"10.1016\/j.brainres.2019.146549_b0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/13854046.2016.1191676","article-title":"Neuropsychological characterization of three adolescent females with anti-NMDA receptor encephalitis in the acute, post-acute, and chronic phases: an inter-institutional case series","volume":"31","author":"Hinkle","year":"2017","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.brainres.2019.146549_b0210","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s00415-016-8282-1","article-title":"Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis","volume":"263","author":"Huang","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0215","first-page":"18927","article-title":"Clinical analysis on anti-N-methyl-D-aspartate receptor encephalitis cases: Chinese experience","volume":"8","author":"Huang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.brainres.2019.146549_b0220","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2019.146549_b0225","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal","volume":"70","author":"Iizuka","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.brainres.2019.146549_b0230","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaneurol.2016.0232","article-title":"Association of progressive cerebellar atrophy with long-term outcome in patients with anti-N-methyl-D-aspartate receptor encephalitis","volume":"73","author":"Iizuka","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0235","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"23","key":"10.1016\/j.brainres.2019.146549_b0240","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1212\/01.wnl.0000336648.43562.59","article-title":"Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab","volume":"71","author":"Ishiura","year":"2008","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.brainres.2019.146549_b0245","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5692\/clinicalneurol.50.103","article-title":"Anti-NMDA receptor encephalitis during pregnancy","volume":"50","author":"Ito","year":"2010","journal-title":"Rinsho Shinkeigaku."},{"issue":"18","key":"10.1016\/j.brainres.2019.146549_b0250","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0000000000000384","article-title":"Transplacental transfer of NMDA receptor antibodies in an infant with cortical dysplasia","volume":"82","author":"Jagota","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.brainres.2019.146549_b0255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yebeh.2017.12.005","article-title":"Allergy in patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"79","author":"Jiang","year":"2018","journal-title":"Epilepsy Behavior: E&B"},{"key":"10.1016\/j.brainres.2019.146549_b0260","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.0b013e3181f8831a","article-title":"Anti-NMDA receptor encephalitis causing prolonged nonconvulsive statusepilepticus","volume":"75","author":"Johnson","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.brainres.2019.146549_b0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2169\/internalmedicine.54.2047","article-title":"Refractory status epilepticus caused by anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide","volume":"54","author":"Kadoya","year":"2015","journal-title":"Intern Med."},{"issue":"2","key":"10.1016\/j.brainres.2019.146549_b0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/practneurol-2018-002042","article-title":"Anti-NMDAR encephalitis complicating pregnancy","volume":"19","author":"Kalam","year":"2019","journal-title":"Pract Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0275","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157340011797183184","article-title":"Anti-NMDA Receptor Encephalitis in Psychiatry","volume":"7","author":"Kayser","year":"2011","journal-title":"Current psychiatry reviews."},{"issue":"11","key":"10.1016\/j.brainres.2019.146549_b0280","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ene.13759","article-title":"Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment","volume":"25","author":"Keddie","year":"2018","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0285","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3174\/ajnr.A5086","article-title":"Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis","volume":"38","author":"Kelley","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146549_b0290","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/jog.13892","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis during pregnancy: A case report","volume":"45","author":"Keskin","year":"2019","journal-title":"J Obstet Gynaecol Res."},{"issue":"1","key":"10.1016\/j.brainres.2019.146549_b0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14581\/jer.15008","article-title":"Anti-NMDA receptor encephalitis in a pregnant woman","volume":"5","author":"Kim","year":"2015","journal-title":"J. Epilepsy Res."},{"issue":"7","key":"10.1016\/j.brainres.2019.146549_b0300","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archneurol.2010.133","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy","volume":"67","author":"Kumar","year":"2010","journal-title":"Arch Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2019.146549_b0305","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.genhosppsych.2014.02.010","article-title":"Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions","volume":"36","author":"Kuppuswamy","year":"2014","journal-title":"Gen Hosp Psychiatry."},{"issue":"5","key":"10.1016\/j.brainres.2019.146549_b0310","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/AOG.0000000000000548","article-title":"Maternal-fetal transfer of anti-N-methyl-D-aspartate receptor antibodies","volume":"125","author":"Lamale-Smith","year":"2015","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.brainres.2019.146549_b0315","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.brainres.2019.146549_b0320","article-title":"Neuroleptic intolerance in patients with anti-NMDAR encephalitis","volume":"3","author":"Lejuste","year":"2016","journal-title":"Neurology(R) Neuroimmunology & Neuroinflammation"},{"key":"10.1016\/j.brainres.2019.146549_b0325","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0330","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(13)70070-X","article-title":"Prevalence and treatment of anti-NMDA receptor encephalitis","volume":"12","author":"Liba","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome","volume":"10","author":"Lim","year":"2014","journal-title":"J. Clin. Neurol (Seoul, Korea)"},{"key":"10.1016\/j.brainres.2019.146549_b0340","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cca.2018.01.016","article-title":"Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"480","author":"Liu","year":"2018","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.brainres.2019.146549_b0345","doi-asserted-by":"crossref","first-page":"6361479","DOI":"10.1155\/2017\/6361479","article-title":"Anti-N-Methyl-D-aspartate receptor encephalitis: a severe, potentially reversible autoimmune encephalitis","volume":"2017","author":"Liu","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.brainres.2019.146549_b0350","first-page":"221","article-title":"N-methyl-D-aspartate receptors mediate epilepsy-induced axonal impairment and tauphosphorylation via activating glycogen synthase kinase-3beta andcyclin-dependent kinase 5","volume":"23","author":"Liu","year":"2017","journal-title":"Discovery medicine."},{"key":"10.1016\/j.brainres.2019.146549_b0355","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/epi.13929","article-title":"Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study","volume":"58","author":"Liu","year":"2017","journal-title":"Epilepsia."},{"key":"10.1016\/j.brainres.2019.146549_b0360","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208052","article-title":"Acute psychosis in a pregnant patient with Graves' hyperthyroidism and anti-NMDA receptor encephalitis","volume":"2015","author":"Lu","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.brainres.2019.146549_b0365","first-page":"235","article-title":"Anti-NMDA Receptor Encephalitis: Clinical Features and Basic Mechanisms. Advances in pharmacology (San","volume":"82","author":"Lynch","year":"2018","journal-title":"Diego, Calif.)"},{"issue":"2 Pt 2","key":"10.1016\/j.brainres.2019.146549_b0370","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/AOG.0b013e31825935d4","article-title":"Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis","volume":"120","author":"Magley","year":"2012","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.brainres.2019.146549_b0375","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/acn3.444","article-title":"NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody","volume":"4","author":"Malviya","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0380","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-5-31","article-title":"In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction","volume":"5","author":"Manto","year":"2010","journal-title":"Orphanet J. Rare Diseases"},{"key":"10.1016\/j.brainres.2019.146549_b0385","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology."},{"issue":"26","key":"10.1016\/j.brainres.2019.146549_b0390","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001034","article-title":"Anti-NMDA receptor encephalitis during pregnancy: a case report","volume":"94","author":"Mathis","year":"2015","journal-title":"Medicine (Baltimore)."},{"issue":"12","key":"10.1016\/j.brainres.2019.146549_b0395","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1007\/s00415-012-6561-z","article-title":"Anti-NMDA receptor encephalitis with associated catatonia during pregnancy","volume":"259","author":"McCarthy","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0400","doi-asserted-by":"crossref","first-page":"7967526","DOI":"10.1155\/2016\/7967526","article-title":"Profound autonomic instability complicated by multiple episodes of cardiac asystole and refractory bradycardia in a patient with anti-NMDA encephalitis","volume":"2016","author":"Mehr","year":"2016","journal-title":"Case reports in neurological medicine."},{"key":"10.1016\/j.brainres.2019.146549_b0405","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain : a journal of neurology."},{"key":"10.1016\/j.brainres.2019.146549_b0410","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/dmcn.12882","article-title":"Symptomatic treatment of children with anti-NMDAR encephalitis","volume":"58","author":"Mohammad","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0415","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2019.146549_b0420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12969-019-0310-0","article-title":"Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy","volume":"17","author":"Moussa","year":"2019","journal-title":"Pediatr Rheumatol Online J."},{"key":"10.1016\/j.brainres.2019.146549_b0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0035-1569464","article-title":"Clinical features, therapeutic response, and follow-up in pediatric anti-N-methyl-D-aspartate receptor encephalitis: experience from a Tertiary Care University Hospital in India","volume":"47","author":"Nagappa","year":"2016","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.brainres.2019.146549_b0430","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment forAlzheimer's disease, vascular dementia and Parkinson's disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.brainres.2019.146549_b0435","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2012.03.001","article-title":"Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology","volume":"11","author":"Peery","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.brainres.2019.146549_b0440","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fimmu.2019.00103","article-title":"Cell-free mitochondrial DNA in the CSF: a potential prognostic biomarker of anti-NMDAR encephalitis","volume":"10","author":"Peng","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2019.146549_b0445","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jca.20311","article-title":"Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis","volume":"26","author":"Pham","year":"2011","journal-title":"J. Clin. Apheresis"},{"key":"10.1016\/j.brainres.2019.146549_b0450","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.146549_b0455","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.24721","article-title":"Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity","volume":"80","author":"Planaguma","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0460","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sbi.2015.07.012","article-title":"A structural biology perspective on NMDA receptor pharmacology and function","volume":"33","author":"Regan","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.brainres.2019.146549_b0465","doi-asserted-by":"crossref","first-page":"E9916","DOI":"10.1073\/pnas.1804846115","article-title":"NMDA-receptor antibodies alter cortical microcircuit dynamics","volume":"115","author":"Rosch","year":"2018","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.brainres.2019.146549_b0470","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMcpc0804644","article-title":"Case records of the Massachusetts General Hospital. Case 26\u20132008. A 26-year-old woman with headache and behavioral changes","volume":"359","author":"Sabin","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.brainres.2019.146549_b0475","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Increased cortical GABA concentrations in depressed patients receiving ECT","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.brainres.2019.146549_b0480","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv102","article-title":"D-Cycloserine in neuropsychiatric diseases: a systematic review","volume":"19","author":"Schade","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2019.146549_b0485","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaac.2014.12.014","article-title":"Treatment of delirium in the context of anti-N-methyl-D-aspartate receptor antibody encephalitis","volume":"54","author":"Scharko","year":"2015","journal-title":"J. Am. Acad. Child Adolesc Psychiatry."},{"key":"10.1016\/j.brainres.2019.146549_b0490","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","article-title":"Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis","volume":"88","author":"Scheibe","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.146549_b0495","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clineuro.2018.06.005","article-title":"Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis","volume":"172","author":"Schroeder","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.brainres.2019.146549_b0500","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208823","article-title":"Steroid unresponsive anti-NMDA receptor encephalitis during pregnancy successfully treated with plasmapheresis","volume":"2015","author":"Shahani","year":"2015","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.brainres.2019.146549_b0505","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tjog.2017.04.009","article-title":"Anti-N-Methyl-d-Aspartate receptor (NMDAR) encephalitis during pregnancy: clinical analysis of reported cases","volume":"56","author":"Shi","year":"2017","journal-title":"Taiwanese J. Obstetrics Gynecol."},{"key":"10.1016\/j.brainres.2019.146549_b0510","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/acn3.557","article-title":"Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis","volume":"5","author":"Shin","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0515","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/acschemneuro.8b00304","article-title":"N-Methyl-d-aspartate receptor antibody encephalitis: a concise review of the disorder, diagnosis, and management","volume":"10","author":"Staley","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.brainres.2019.146549_b0520","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3892\/etm.2015.2689","article-title":"Heterogeneity of clinical features and corresponding antibodies in seven patients with anti-NMDA receptor encephalitis","volume":"10","author":"Suhs","year":"2015","journal-title":"Exp. Therapeutic Med."},{"key":"10.1016\/j.brainres.2019.146549_b0525","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.braindev.2016.01.009","article-title":"Plasma exchange in pediatric anti-NMDAR encephalitis: A systematic review","volume":"38","author":"Suppiej","year":"2016","journal-title":"Brain & development."},{"key":"10.1016\/j.brainres.2019.146549_b0530","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jneuroim.2017.08.011","article-title":"Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis","volume":"312","author":"Sveinsson","year":"2017","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.brainres.2019.146549_b0535","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/brain\/awy107","article-title":"Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibodyencephalitis","volume":"141","author":"Symmonds","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.146549_b0540","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chc.2018.07.005","article-title":"Anti-N-Methyl d-aspartate receptor encephalitis and electroconvulsive therapy: literature review and future directions","volume":"28","author":"Tanguturi","year":"2019","journal-title":"Child Adolescent Psychiatric Clinics North America"},{"key":"10.1016\/j.brainres.2019.146549_b0545","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0550","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","article-title":"Late-onset anti-NMDA receptor encephalitis","volume":"81","author":"Titulaer","year":"2013","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.brainres.2019.146549_b0555","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaneurol.2016.0530","article-title":"The association between atrophy and the prognosis of anti-N-methyl-d-aspartate receptor encephalitis","volume":"73","author":"Titulaer","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0560","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainres.2019.146549_b0565","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1021\/acschemneuro.7b00319","article-title":"Anti-NMDA-receptor encephalitis: from bench to clinic","volume":"8","author":"Venkatesan","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2019.146549_b0570","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0000000000000126","article-title":"Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis","volume":"82","author":"Viaccoz","year":"2014","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.brainres.2019.146549_b0575","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2019.146549_b0580","first-page":"125","article-title":"Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children","volume":"57","author":"Wang","year":"2019","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"10.1016\/j.brainres.2019.146549_b0585","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2741\/4412","article-title":"Efficacies of treatments for anti-NMDA receptor encephalitis","volume":"21","author":"Wang","year":"2016","journal-title":"Front. Biosci. (Landmark edition)."},{"key":"10.1016\/j.brainres.2019.146549_b0590","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ene.12911","article-title":"Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China","volume":"23","author":"Wang","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0595","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","volume":"138","author":"Warren","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.brainres.2019.146549_b0600","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brs.2018.11.016","article-title":"Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: a systematic review of cases","volume":"12","author":"Warren","year":"2019","journal-title":"Brain stimulation."},{"key":"10.1016\/j.brainres.2019.146549_b0605","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0169-328X(98)00211-3","article-title":"Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b","volume":"61","author":"Watkins","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.brainres.2019.146549_b0610","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1073858404269012","article-title":"N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease","volume":"11","author":"Waxman","year":"2005","journal-title":"Neuroscientist"},{"issue":"6","key":"10.1016\/j.brainres.2019.146549_b0615","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psym.2013.03.002","article-title":"Anti-NMDA receptor encephalitis in a 14-year-old female presenting as malignant catatonia: medical and psychiatric approach to treatment","volume":"54","author":"Wilson","year":"2013","journal-title":"Psychosomatics."},{"key":"10.1016\/j.brainres.2019.146549_b0620","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/archdischild-2014-306795","article-title":"N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children","volume":"100","author":"Wright","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.brainres.2019.146549_b0625","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","article-title":"Targeting NMDA receptors in stroke: new hope in neuroprotection","volume":"11","author":"Wu","year":"2018","journal-title":"Molecular brain."},{"issue":"4","key":"10.1016\/j.brainres.2019.146549_b0630","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/jog.13262","article-title":"Anti-NMDA-receptor encephalitis during pregnancy: a case report and literature review","volume":"43","author":"Xiao","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.brainres.2019.146549_b0635","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.08.010","article-title":"Neurobehavioral outcomes in autoimmune encephalitis","volume":"312","author":"Yeshokumar","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2019.146549_b0640","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0074-7742(05)72013-4","article-title":"ECT and the youth: catatonia in context","volume":"72","author":"Zaw","year":"2006","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.brainres.2019.146549_b0645","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00415-015-7781-9","article-title":"Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis","volume":"262","author":"Zekeridou","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2019.146549_b0650","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/abbs\/gmy137","article-title":"Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis","volume":"50","author":"Zeng","year":"2018","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.brainres.2019.146549_b0655","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity ina mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.146549_b0660","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.146549_b0665","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-019-00725-4","article-title":"Efficacy of therapeutic plasma exchange in patients with severe refractory anti-NMDA receptor encephalitis","author":"Zhang","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brainres.2019.146549_b0670","first-page":"781","article-title":"[Progress in immunotherapy for children with anti-N-methyl-D-aspartate receptor encephalitis]","volume":"20","author":"Zhang","year":"2018","journal-title":"Zhongguo dang dai er ke za zhi = Chinese Journal of Contemporary Pediatrics"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319306031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319306031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:11:37Z","timestamp":1757787097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319306031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":134,"alternative-id":["S0006899319306031"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146549","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-N-methyl-D-aspartate receptor encephalitis: A review of pathogenic mechanisms, treatment, prognosis","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.146549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"146549"}}